Biofrontera Inc (BFRI NASDAQ) stock market data APIs
$0.8964
0.06(6.7%)
as of November 13, 2025
Try our APIs with
free plan!
Biofrontera Inc Financial Data Overview
Price chart is built with
Anychart
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a common skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Prev. Close
0.8964
Open
0.9578
High
1.0176
Low
0.8897
52 wk Range
0.536-1.2539
Market Cap
9 496 K
Shares Outstanding
10 668 K
Revenue
39 188 K
EPS
-0.5687
Beta
0.565
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Biofrontera Inc data using free add-ons & libraries
Get Biofrontera Inc Fundamental Data
Biofrontera Inc Fundamental data includes:
- Net Revenue: 39 188 K
- EBITDA: -16 083 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-09-30
- EPS/Forecast: -0.56
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Biofrontera Inc News
New
Biofrontera Inc. Reports Third Quarter 2025 Financial Results and Provides a Business Update
Conference call will be held today, Thursday, November 13 at 10:00 am ET Woburn, MA, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company sp...
Biofrontera reports Q3 results
* Biofrontera press release [https://seekingalpha.com/filing/38897076] (BFRI [https://seekingalpha.com/symbol/BFRI]): Q3 GAAP EPS of -$0.62. * Revenue of $6.98M (-22.5% Y/Y). MORE ON BIOFRONTERA ...
Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Lags Revenue Estimates
Roivant Sciences Ltd. (ROIV) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.29 per share a year ago. These figu...
Biofrontera Inc. announces sale of license to Xepi® Antibiotic Cream to Pelthos Therapeutics Inc. for up to $10M
Proceeds of up to $10 million, consisting of $3 million at closing, $1 million upon availability of commercial product, and up to $6 million in sales-related milestone payments. Transaction further bo...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
